文献速递食管胃疾病与幽门螺杆菌消化内镜

实时评估幽门螺杆菌感染以指导分子抗生素耐药性检测:内镜联合胃液分析的方法

Real-Time Assessment of H. pylori Infection to Guide Molecular Antibiotic Resistance Testing: A Combined Endoscopy-Gastric Juice Analysis Approach.
PubMed 文献 · Aliment Pharmacol Ther · 2024-11-12

本研究纳入461例计划接受内镜的患者,术中使用Endofaster联合胃液分析实时检测幽门螺杆菌,对阳性者采集胃液和活检组织,比较胃液基因型药敏试验(G-AST)与常规表型药敏试验(P-AST)检测克拉霉素和左氧氟沙星耐药的诊断准确性。结果显示G-AST与P-AST高度一致,克拉霉素和左氧氟沙星的诊断准确性分别为97%和95%。作者认为该联合方法可用于指导幽门螺杆菌根除方案。

要点

  • 461例接受内镜患者中178例(40.4%)术中检测幽门螺杆菌阳性。
  • 152例配对样本中,P-AST显示克拉霉素耐药率15.1%(23/152),左氧氟沙星耐药率18.4%(28/152)。
  • G-AST与P-AST一致性高:克拉霉素kappa 0.86,左氧氟沙星kappa 0.81;诊断准确性分别为97%和95%。

核心结论

  • 内镜联合术中胃液分析检测幽门螺杆菌、阳性时行药敏试验的方法,对于制定幽门螺杆菌感染根除方案是有效且实用的。
  • 胃液基因型药敏试验检测克拉霉素和左氧氟沙星耐药具有高准确性。

研究设计与样本

  • 研究纳入461例连续计划接受内镜的患者。
  • 术中使用Endofaster(结合内镜与胃液分析的新方法)实时检测幽门螺杆菌。
  • 对幽门螺杆菌阳性患者采集胃液和活检组织;胃液基因型药敏试验(G-AST)采用Sanger测序检测23S rRNA和gyrA基因多态性,分别对应大环内酯类和氟喹诺酮类耐药;活检分离菌株采用ETEST行表型药敏试验(P-AST)。

主要发现

  • 178例(40.4%)患者在内镜检查期间检测为幽门螺杆菌阳性。
  • 152例幽门螺杆菌阳性患者有配对的胃活检和胃液样本。
  • P-AST显示克拉霉素耐药率为15.1%(23/152),左氧氟沙星耐药率为18.4%(28/152)。
  • G-AST与P-AST在克拉霉素耐药检测上kappa值为0.86,在左氧氟沙星耐药检测上kappa值为0.81;诊断准确性分别为97%和95%。

临床怎么用

  • 原文结论认为该联合方法可用于指导幽门螺杆菌感染的根除方案制定。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Helicobacter pylori antibiotic resistance is the most relevant cause of treatment failure. Antibiotic susceptibility testing (AST) allows for selecting the appropriate eradication regimen. AIMS: To assess the diagnostic accuracy of gastric aspirate-based genotypic AST (G-AST) for detecting clarithromycin and levofloxacin resistance compared with conventional phenotypic AST (P-AST). METHODS: We recruited 461 consecutive patients scheduled for endoscopy. H. pylori was detected intraprocedurally using Endofaster, a novel method combining endoscopy with gastric juice analysis. For H. pylori-positive patients, we collected gastric aspirates and biopsies. G-AST was performed using DNA extracted from aspirates, with Sanger sequencing to detect polymorphisms in the 23S rRNA and gyrA genes associated, respectively, with resistance to macrolides and fluoroquinolones. P-AST was performed on H. pylori isolated from biopsies using ETEST. RESULTS: One hundred and seventy-eight (40.4%) patients tested positive for H. pylori during endoscopy. Paired gastric biopsies and aspirates were available from 152 H. pylori-positive patients. By P-AST, resistance rates were 15.1% (23/152) for clarithromycin and 18.4% (28/152) for levofloxacin. G-AST showed a high level of agreement with P-AST for clarithromycin (kappa 0.86) and levofloxacin (kappa 0.81) resistance and diagnostic accuracy of 97% and 95%, respectively. CONCLUSIONS: The novel method combining endoscopy with immediate intraprocedural gastric juice analysis for the detection of H. pylori, followed by AST in case of a positive finding, is valid and practical for tailoring eradication regimens for H. pylori infection. Genotypic AST from gastric aspirates is highly accurate for detecting clarithromycin and levofloxacin resistances.

来源:Aliment Pharmacol Ther,查看原文。版权归原作者所有。

引用

  1. Vasapolli R, Ailloud F, Spießberger B, et al. Real-Time Assessment of H. pylori Infection to Guide Molecular Antibiotic Resistance Testing: A Combined Endoscopy-Gastric Juice Analysis Approach. Aliment Pharmacol Ther. 2024. PMID: 39530235. doi:10.1111/apt.18378

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。